Aberrations in Met-hepatocyte growth factor/scatter factor (HGF/SF) signaling have been implicated in the acquisition of tumorigenic and metastatic phenotypes. Here we show that murine NIH3T3 and C127 cells transformed by the Ras oncogene overexpress the Met receptor, resulting in enhanced HGF/SF-mediated responses in vitro including invasion through basement membrane. Accompanying the increase in Met in rastransformed NIH3T3 cells, there is a decrease in endogenous HGF/SF expression as previously observed in cells exogenously overexpressing Met. However, subcutaneously grown tumors and experimental lung metastases derived from these cells express signi®cantly higher levels of endogenous HGF/SF together with high levels of Met. These results suggest Met-HGF/SF signaling enhances tumor growth and metastasis of Ras-transformed NIH3T3 cells.
Introduction
The product of the met proto-oncogene is the transmembrane tyrosine kinase p190
Met (Park et al., 1986) , which has been identi®ed as the receptor for hepatocyte growth factor/scatter factor (HGF/SF) (Bottaro et al., 1991) . HGF/SF is a polypeptide growth factor produced predominantly by cells of mesenchymal origin, which elicits a variety of eects in vitro on target cells expressing Met including the induction of cell proliferation, dierentiation, invasion and motility (reviewed by Rubin et al., 1993; Vande Woude et al., 1997) . While HGF/SF-Met signaling has been shown to be important in a number of normal physiological processes, we and others have shown that aberrant HGF/SF-Met signaling leads to the development of tumors and metastases (reviewed by Jeers et al., 1996b) . In addition, Met and/or HGF/SF are frequently found to be overexpressed in a variety of tumor tissues, providing further evidence for their involvement in tumor formation/metastasis (reviewed by Jeers et al., 1996b) .
Members of the Ras family of small GTPases (H-, K-and N-Ras) are frequently mutated (activated) in a number of human tumors (Bos, 1989) , and in addition, oncogenic mutants of Ras have been shown to confer both tumorigenic and metastatic phenotypes to a variety of cell types in culture (Bondy et al., 1985; Greig et al., 1985; Muschel et al., 1985; Thorgeirsson et al., 1985) . Although a number of downstream genetic events have been characterized in Ras-transformed cells, precisely which of these are important for the acquisition of the tumorigenic and metastatic phenotypes are poorly understood (Chambers and Tuck, 1993) . In this paper we demonstrate that two Rastransformed murine cell lines, NIH3T3 and C127 cells, express higher levels of Met when compared with their non-transformed counterparts. As a result, Rastransformed cells are signi®cantly more responsive to HGF/SF in vitro. In addition we show that Rastransformed NIH3T3 cells expressing high levels of Met express signi®cantly lower levels of endogenous HGF/SF. However, both tumors and experimental lung metastases derived from injecting these cells into athymic nude mice express high levels of both Met and HGF/SF. These results suggest that autocrine Met-HGF/SF signaling enhances Ras-mediated tumorigenicity and metastasis of NIH3T3 cells and may be important for understanding the genetic events leading to tumorigenesis and metastasis.
Results

Met is overexpressed in Ras-transformed cells
Stable cell lines of NIH3T3 and C127 cells expressing the human HA-tagged V12-Harvey ras oncogene were generated as described in Materials and methods. Expression of the Ras oncoprotein was con®rmed by Western blotting using an antibody against the HA epitope ( Figure 1a) . To determine the level of Met expression in Ras-transformed cells, Met proteins were immunoprecipitated and analysed by Western blotting using an antibody against the C terminus of murine Met. As shown in Figure 1b , Ras transformed NIH3T3 and C127 cells both expressed higher levels of Met compared to the non-transformed counterparts. In NIH3T3 cells, this increase was most notable in the p140
Met mature bchain (containing the tyrosine kinase domain) and less so in the p170
Met precursor (Iyer et al., 1990) . In Ras transformed C127 cells, both p140
Met and p170 Met were increased above parental levels. As a consequence of overexpressing Met, the level of p140 Met tyrosine phosphorylation was substantially higher in the Met immunoprecipitates from Ras-transformed cells following HGF/SF stimulation, when compared with nontransformed parental cells (Figure 1b ). In addition, we noted reduced basal Met phosphorylation in Rastransformed NIH3T3 cells when compared with parental cells (compare lanes 1 and 3), despite higher levels of Met expression in the former, suggesting that alterations in autocrine HGF/SF-Met signaling may accompany increased Met expression in Ras-transformed NIH3T3 cells. Infection of both NIH3T3 and C127 cells with the Harvey Ras Murine Sarcoma Virus resulted in elevated Met expression after 48 h (data not shown).
To further characterize Met expression in Rastransformed cells, we performed immuno¯uorescence microscopic analysis of Met on parental and Rastransformed NIH3T3 cells. Although some heterogeneity in Met staining was observed, the levels of Met were notably higher in Ras-transformed NIH3T3 cells when compared with parental cells (Figure 2 ). In addition, Met appeared to localize predominantly to or close to the highly refractile pseuodopodia in Rastransformed NIH3T3 cells and intense staining was frequently observed on the membrane rues at the leading edges (arrows).
We also performed Northern blot analysis on total RNA from parental and Ras-transformed cells. Met RNA was increased in both Ras-transformed NIH3T3 cells and C127 cells (Figure 3a) . In addition to cellular pools, we obtained individual clones of C127 cells, and a clear correlation between the level of Ras and Met protein expression was observed (data not shown). One particular clone (C127-Ras2) which expressed the highest level of the Ras oncoprotein, expressed the Figure 3b , lanes 3 ± 5) or protein (Jeers et al., 1996a) .
Ras-transformed cells display increased invasive properties in response to HGF/SF
To investigate the signi®cance of increased Met expression and enhanced HGF/SF sensitivity in Rastransformed cells, we performed a matrigel basement membrane invasion assay using C127 cells (Figure 4 ). This assay measures the ability of cells to migrate through basement membrane (Matrigel), and mimics aspects of tumor cell invasion during the metastatic process. In the absence of HGF/SF, both control and Ras-transformed cells displayed poor invasive properties ( Figure 4b ). Following the addition of HGF/SF, parental C127 cells showed only a modest increase in matrigel invasion (1.6-fold above controls). However, Ras-transformed cells displayed signi®cantly enhanced invasive properties in response to HGF/SF stimulation (5.7-fold above controls) as a result of overexpressing Met. Thus, the presence of the ras oncogene in C127 cells potentiates HGF/SF-mediated invasion through basement membrane.
Increased Met-HGF/SF expression in Ras-mediated tumors and experimental metastases
To begin to test whether Met-HGF/SF signaling is important for ras-mediated tumorigenesis and metastasis, ras-transformed NIH3T3 cells were injected both subcutaneously and into the tail vein of athymic nude mice. Resulting subcutaneous (SC) tumors and experimental lung metastasis (ELM) were then examined for Met and HGF/SF expression. Tumor and metastases-derived cell lines expressed the same level of the V12 H-Ras oncoprotein as the pooled cells prior to injection (Figure 5a ). Similarly, Met RNA from tumor and metastases-derived cell lines was at the high level observed in Ras-transformed cells prior to injection (Figure 5b ). However, both subcutaneous tumors and experimental lung metastases expressed signi®cantly higher levels of HGF/SF RNA when compared with cells prior to injection (Figure 5c ), although not to the level observed in parental NIH3T3 cells. This increase was more notable in the smaller HGF/SF transcripts which encode truncated isoforms (Rubin et al., 1993) . This was also observed at the protein (activity) level. Whereas the TCS from pooled Ras-transformed NIH3T3 cells contained no detectable scattering activity as described above, that of subcutaneous tumor-derived and metastases-derived cells contained, on average, 4 U/ml and 6 U/ml respectively. The higher activity in cultures derived from experimental lung metastases agreed with the higher level of HGF/SF RNA when compared with cultures from SC tumors ( Figure 5c ). We also observed that the basal level of Met autophosphorylation was higher in cultures derived from lung metastases compared with Ras-transformed cells prior to injection (Figure 6 ), providing further evidence for increased autocrine HGF/SF-Met signaling. These data demonstrate that ras-transformed NIH3T3 cells expressing high levels of Similar experiments were performed using clonal populations of C127 cells expressing varying levels of the Ras oncogene and Met. Cells expressing high levels of Ras and Met were more highly tumorigenic and metastatic in experimental assays when compared with cells in which expression of Ras and Met were low (data not shown).
Discussion
Aberrant Met-HGF/SF signaling has been implicated in the etiology of tumors and the development of secondary metastasis (reviewed by Jeers et al., 1996b) . The ras oncogene has also been strongly implicated in the development and progression of tumors, and along with mutations in the p53 tumor suppressor protein represents the most common mutation observed in human malignancies (Bos, 1989) . Here, we describe the eect that Ras-transformation has on Met-HGF/SF expression in two murine cell lines. We have shown that Met expression, at both the protein and RNA level is increased as a result of Ras-transformation in NIH3T3 and C127 cells. Since we also observe an increase in Met expression 48 h after infection with the Harvey Ras Murine Sarcoma Virus, this eect is unlikely due to long term adaption during culture. The increase in Met RNA further suggests that this occurs at the level of gene regulation. This is also supported by the recent ®ndings of Ivan et al. (1997) who showed that upon induction of Ras expression in a human thyroid epithelial cell line, Met expression is elevated within 4 days. Although it remains unclear as to the precise transcriptional targets that mediate this eect, it was recently shown that the Ets-1 transcription factor, a known target of Ras (Galang et al., 1994) , induces Met expression in mouse liver progenitor cells and human gastric carcinoma cell lines (Gambarotta et al., 1996) , suggesting that this represents at least one means by which Ras may directly regulate Met gene expression. Our results also show that in parallel with increased Met expression, Ras-transformed cells express reduced HGF/SF. This suggests that endogenous HGF/SF expression is downregulated as a consequence of Met overexpression and is similar to our previous ®ndings in which HGF/SF protein was lower in the TCS of NIH3T3 cells overexpressing Met mu (Rong et al., 1993b) . We cannot exclude the possibility that activated Ras directly down-regulates endogenous HGF/SF expression, resulting in an indirect increase in Met expression through increased Met stability. However, since Ras increases Met expression in C127 cells, which express no endogenous HGF/SF, our data collectively suggest that increased Met gene expression is a direct result of Ras transformation.
We show that, as a consequence of Met overexpression, Ras-transformed cells are more responsive to exogenous HGF/SF stimulation. This is observed at both the level of receptor activation (Met tyrosine phosphorylation), and also in an in vitro matrigel invasion assay. Invasion through basement membrane is a requirement for tumor cell metastasis. Our data suggest that HGF/SF may confer an important exogenous signal to Ras-transformed C127 and NIH3T3 cells during this process when HGF/SF is provided in either a paracrine fashion from tumor stroma, or through autocrine production by the tumor cells themselves. Our data suggest that enhanced autocrine HGF/SF expression in NIH3T3 cells may play an important role in the etiology of Ras-mediated experimental lung metastasis, since cells constituting the lung metastases express signi®cantly higher levels of HGF/SF when compared with cells prior to injection, resulting in increased autocrine Met activation. This occurs strictly through selection and implicates an epigenetic process (i.e., cells expressing higher levels of HGF/SF), as previously suggested (Rong et al., 1994) , in contributing to tumor progression. Conversely, activation of Met in Ras-transformed C127 cells is likely to occur in vivo through a paracrine mechanism since they produce no endogenous HGF/SF. While we have previously shown that overexpression of Met alone is insucient to transform parental C127 cells (Jeers et al., 1996a) , our data suggests that enhanced Met expression may contribute to the tumorigenic and/ or metastatic phenotypes in Ras-transformed C127 cells. HGF/SF possesses a number of characteristics essential for the development of tumors and metastases, such as activation of the ECM proteolysis network (reviewed by Jeers et al., 1996b) , cell proliferation (Nakamura, 1992) , and is also a potent angiogenic factor in vivo (Bussolino et al., 1992; Grant et al., 1993) . The increased expression of HGF/SF in the tumors and metastases derived from Ras-transformed NIH3T3 cells likely re¯ects the role that HGF/ SF plays in these processes.
While Ras has been shown to alter the expression pro®les of a number of genes associated with the acquisition of the metastatic phenotype, it remains unclear precisely which of these are truly important for the formation of metastases (Chambers and Tuck, 1993) . For example, Ras has been shown to induce many genes associated with degradation of the ECM including collagenases and cysteine proteinases, and these are likely to be important during the extravasative stages of metastasis. Our results suggest that Met-HGF/SF signaling may also play some role in these events and we are currently testing this hypothesis more rigorously. While it remains unclear at present precisely how much Met overexpression is required to confer a selective advantage during tumor growth and/or metastasis, our data clearly show that the observed increase in Met expression is sucient to potentiate Met-HGF/SF-mediated invasion in vitro. In addition, a clear correlation exists between the activity of the recently identi®ed activating Met mutants and tumorigenic properties, directly implicating enhanced Met expression/activity during tumor growth . We have previously shown that p53 ± / ± mouse ®broblasts when passaged in vitro overexpress Met and become tumorigenic in athymic nude mice (Rong et al., 1995) , and most human osteosarcoma cell lines that overexpress Met are compromised for p53 function (Rong et al., 1993a) . Thus, the two most common mutations observed in human tumors, namely those at the Ras and p53 loci, result in inappropriate Met expression in mouse ®broblasts. A number of human cancers, including pancreatic, colon, thyroid and gastric carcinoma, have been shown to overexpress the Met receptor (Jeers et al., 1996b) and this may be associated with the presence of activating mutations in Ras or loss of p53 function frequently found in these tumors (Bos, 1989) . Such increases in Met expression could lead to the development of a more aggressive phenotype, and to the formation of tumor metastases.
Materials and methods
Expression plasmids and cell lines
The pDCR-(V12) Ha-ras mammalian construct which encodes an N-terminal HA-tagged transforming human Harvey Ras (V12) oncoprotein in which expression is under the control of the cytomegalovirus promoter (White et al., 1995) was a kind gift from M Wigler (CSHL, New York USA). NIH3T3 (490) cells were obtained from D Blair (Frederick, MD USA) and C127-I cells from American Type Culture Collection. Both cell lines were grown in Dulbecco's modi®ed Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS; Gibco) at 378C in a humidi®ed atmosphere of 10% CO 2 . MDCK canine kidney epithelial cells were a kind gift from I Tsarfaty (Tel Aviv University, Israel), and were grown as above in DMEM/5% FBS.
Transfections and viral infections
DNA transfections were performed using the DOTAP reagent according to the manufacturer's instructions (Boehringer Mannheim). In brief, cells were cultured to approximately 50% con¯uence on 100 mm diameter tissue culture dishes. Ten micrograms of plasmid DNA in the DOTAP reagent were applied to each dish for 6 h. Cells were washed three times with phosphate buered saline (PBS), and once with DMEM/10% FBS, prior to incubation for 24 h in DMEM/10% FBS. Cells were then placed under selection using DMEM/10% FBS containing 400 mg/ml active Geneticin (G418; Boehringer Mannheim). After approximately 2 weeks in selection medium, multiple G418-resistant clones (450) were pooled to establish each cell line. A number of single-cell clones were also expanded and cultured individually. Viral infections using amphotopic Harvey Ras Murine Sarcoma Virus were performed as previously described (Blair et al., 1980) .
Growth factors and MDCK cell scatter assay
Human HGF/SF was puri®ed, as previously described, from the supernatant of transformed NIH3T3 cells that overproduce the factor (Rong et al., 1993b) . HGF/SF concentrations are presented as scatter units per milliliter; ®ve scatter units are equivalent to approximately 1 ng protein. Scatter assays using conditioned tissue culture media collected from cells after 72 h in culture were performed with MDCK cells as described previously (Stoker et al., 1987) .
Immunoprecipitation and Western blotting
Cells were grown to approximately 70% con¯uence on 100 mm diameter tissue culture dishes. Following the treatments as indicated, cells were solubilized by washing twice with ice-cold PBS, and resuspending in 1 ml of icecold lysis buer (20 mM PIPES pH 7.4, 150 mM NaCl, 1 mM EGTA, 1.5 mM MgCl 2 , 1% Triton X-100, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mM PMSF and 1 mM sodium orthovanadate). Cell lysates were clari®ed by centrifugation at 15 000 g for 15 min at 48C, and protein determination was performed on the soluble protein supernatants using a standard assay (Pierce).
For Western analysis, 10 mg of cell lysates were resuspended 3 : 1 into 46Laemmli buer (0.4 M Tris-HCl pH 6.8, 0.4 M DTT, 8% SDS, 39% glycerol, 0.04% bromophenol blue), boiled for 5 min and resolved by SDS ± PAGE. Proteins were then transferred to nitrocellulose, and blots blocked for 1 h with a 5% solution of BSA in TBS buer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1% Tween-20). Blots were then probed for 1 h using the following primary antibodies: anti-hemagglutinin (HA; clone Y-11; Santa Cruz Biotechnology), anti-Met (clone SP260; Santa Cruz Biotechnology) or anti-phosphotyrosine (clone 4G10, Upstate Biotechnology). Blots were then incubated for 1 h with the appropriate secondary antibody coupled to horse radish peroxidase (Boehringer Mannheim), followed by exposure to the ECL-chemiluminescence detection reagents (Amersham) and X-ray ®lm development.
For immunoprecipitation of Met, 0.5 mg of protein sample was adjusted to 1 ml with lysis buer, and incubated overnight at 48C with 10 ml of anti-Met antibody (SP260). Samples were then incubated for 3 h at 48C with 50 ml of a 20% solution of protein-A-agarose (Sigma) to allow coupling to the immune complex. The agarose pellets were then centrifuged for 30 s and the pellets washed three times with lysis buer. The ®nal pellet was resuspended and boiled in 26Laemmli buer and subjected to SDS ± PAGE/Western blot analysis as described above.
Immuno¯uorescence analysis
Cells were grown in 4-well permanox chamber Labtek slides (Nunc) and ®xed for 20 min in 4% paraformaldehyde/PBS. Cells were then permeabilized for 5 min at room temperature with 0.2% Triton X-100/PBS. After extensive PBS washes, cells were blocked for 1 h with 10% goat serum (Gibco), and incubated for 1 h at 378C with 1 : 20 anti-Met antibody (SP260). After further washes, cells were then incubated for 1 h at 378C with 1 : 100 rhodamineconjugated goat anti-rabbit antibody (Boehringer Mannheim). After extensive washing, cells were cover slipped with Gel Mount (Biomeda) and examined with a Zeiss LSM310 CLSM.
Northern blot analysis and cDNA probes
Total cellular RNA was isolated using TRlzol as described by the supplier (Gibco). Fifteen mg of total RNA were denatured, electrophoresed on 1.2% formaldehyde agarose gel, transferred to nylon membranes (Schleicher and Schuell) and used for Northern blot analysis as described previously (Stumpo et al., 1989) . The following cDNAs were used to generate 32 P-labeled probes using the RadPrime DNA labeling system (Gibco): a 676 bp NdeI/ PvuII fragment of pMB11, a murine Met cDNA plasmid (Rong et al., 1992) ; a 2.2 kb BamHI fragment of LA686, a murine HGF/SF cDNA plasmid (a kind gift from D Bottaro, Bethesda); a 1.2 kb PstI fragment of pHcGAP, a human glyceraldehyde-phosphate dehydrogenase (GAPDH) cDNA plasmid (Tso et al., 1985) ; and a 2 kb fragment of pHFbA-1, a human b-actin cDNA plasmid (Gunning et al., 1983) .
Matrigel invasion assays
Invasion of C127 cells through matrigel coated ®lters was performed as previously described (Jeers et al., 1996a) . In brief, 0.2 ml of a 30 000 cells/ml suspension of C127 cells in DMEM supplemented with 1 mg/ml bovine serum albumin (BSA) were applied to the upper side of a Matrigel-coated invasion chamber (Becton Dickinson). The chamber was placed into a 24-well culture plate containing 0.5 ml of DMEM/BSA alone or supplemented with 200 scatter units/ml of HGF/SF, and incubated for 24 h. Non-invasive cells were then removed from the upper side of the ®lter, and invading cells stained using Di-Quik staining solutions (Baxter). The stained cells were photographed and counted.
In vivo tumorigenicity and experimental metastasis assays
The mice utilized in these experiments were ± 4-week-old female athymic nude mice (Ncr nu/nu), which were obtained from the Animal Production Area, NCI-Frederick Cancer Research and Development Center, Frederick, MD, USA. Animal care was provided in accordance with the procedures outlined in the`Guide for the Care and Use of Laboratory Animals' (NIH Publication No. 86-23, 1985) .
For the analysis of tumor growth, trypsinized cells were washed with Hanks' Balanced Salt Solution (HBSS; Gibco) and 10 5 cells in 0.1 ml HBSS were injected subcutaneously into the backs of athymic nude mice. Tumor formation was monitored weekly. For the determination of metastatic abilities, experimental assays were performed as previously described (Jeers et al., 1996a) . In brief, cells were prepared as above and 10 5 cells in 0.1 ml HBSS were injected into the tail veins of athymic nude mice. Animals were sacri®ced when they appeared distressed or after 14 weeks. Tumor-derived cultures were obtained from subcutaneously grown tumors and lung metastases after sacri®cing the animals, dissecting and mincing the tumor tissue, and plating in DMEM/10% FBS medium containing 400 mg/ml active Geneticin to select against growth of host tissue.
Note added in proof Ras-transformed ®broblasts derived from Met 7/7 knockout mice embryos colonize the lung in experimental metastasis assays. Thus, HGF/SF-Met signaling may contribute to the metastatic phenotype of Ras-transformed NIH3T3, but it does not appear necessary for the formation of experimental lung metastasis.
